Although the serum insulin level of diabetic rats exposed to GLB plus MCFE-250 combination did not reach statistical significance for the comparison with GLB monotherapy, a statistically significant difference was observed in favor of GLB plus MCFE-500 combination therapy at the end of the 2nd, 4th and 8th week of medication.
← all excerpts
Molecular and biochemical monitoring of the possible herb-drug interaction between <i>Momordica charantia</i> extract and glibenclamide in diabetic rats.
1
—
—